alemtuzumab

alemtuzumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

General

High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.

**REMS Drug**

Pronunciation:
a-lem-too-zoo-mab


Trade Name(s)

  • Lemtrada
  • MabCampathCanadian Tradename

Ther. Class.
anti-multiple sclerosis agents

Pharm. Class.
monoclonal antibodies

-- To view the remaining sections of this topic, please or purchase a subscription --